Dentsply Sirona misses Q1 revenue, adjusted EPS estimates; backs FY view

DENTSPLY SIRONA

05/05/2026 21:12

Overview

Dental products maker's Q1 revenue was flat yr/yr but beat analyst expectations

Adjusted EPS for Q1 missed analyst expectations, falling 39% yr/yr

Company says near-term results impacted by external pressures and investment timing

Outlook

Dentsply Sirona maintains 2026 net sales outlook at $3.5 bln to $3.6 bln

Company expects 2026 adjusted EPS between $1.40 and $1.50

Dentsply Sirona expects momentum to build throughout 2026 despite near-term external pressures

Result Drivers

COMMERCIAL RESTRUCTURING - Co said ongoing restructuring and transformation efforts affected near-term results

EXTERNAL PRESSURES AND INVESTMENT TIMING - Co said near-term performance was impacted by external pressures and investment timing

SEGMENT WEAKNESS - Essential Dental Solutions and Orthodontic and Implant Solutions segments reported declines in sales

Company press release: ID:nGNX7yltyd

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$880 mln
$840.90 mln (14 Analysts)
Q1 Adjusted EPS
Miss
$0.27
$0.28 (16 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 11 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for DENTSPLY SIRONA Inc is $13.75, about 22.8% above its May 4 closing price of $11.20

The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)